TD Cowen on Ocular Therapeutix (OCUL): 'Great Data Could Lead To 45% Upside Per Investor Survey'
Tweet Send to a Friend
TD Cowen analyst Tara Bancroft reiterated a Buy rating and $20.00 price target on Ocular Therapeutix (NASDAQ: OCUL).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
